ALZHEIMER’S DISEASE

 

Effects of dronabinol on anorexia and disturbed behavior in patients with Alzheimer’s disease.   (abst – 1997)       http://www.cannabis-med.org/studies/ww_en_db_study_show.php?s_id=59

 

Anandamide and noladin ether prevent neurotoxicity of the human amyloid-beta peptide. (abst – 2002)                           http://www.ncbi.nlm.nih.gov/pubmed/12384227

 

US Patent 6630507 – Cannabinoids as antioxidants and neuroprotectants    (full – 2003)

http://www.patentstorm.us/patents/6630507.html

 

Cannabinoid CB2 Receptors and Fatty Acid Amide Hydrolase Are Selectively Overexpressed in Neuritic Plaque-Associated Glia in Alzheimer’s Disease Brains (full – 2003)

http://www.jneurosci.org/content/23/35/11136.full?maxtoshow=&hits=80&RESULTFORMAT=&fulltext=  cannabinoid&searchid=1&FIRSTINDEX=80&resourcetype=HWCIT

 

Safety and efficacy of Dronabinol in the treatment of agitation in patients with Alzheimer’s disease with anorexia                             (abst – 2003)

http://www.cannabis-med.org/studies/ww_en_db_study_show.php?s_id=61

 

Open-label study of  Dronabinol in the treatment of refractory agitation in Alzheimer’s disease : a pilot study                                  (abst – 2003)

http://www.cannabis-med.org/studies/ww_en_db_study_show.php?s_id=92

 

Neuroprotective effect of cannabidiol, a non-psychoactive component from Cannabis sativa, on β-amyloid-induced toxicity in PC12 cells                             (full – 2004)  http://www3.interscience.wiley.com/cgi-bin/fulltext/118757302/HTMLSTART

 

Early age-related cognitive impairment in mice lacking cannabinoid CB1 receptors. (full – 2005)                                    http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1266095/?tool=pubmed

 

Stimulation of cannabinoid receptor 2 (CB2) suppresses microglial activation (full – 2005)                                 http://www.jneuroinflammation.com/content/2/1/29

 

Prevention of Alzheimer’s Disease Pathology by Cannabinoids: Neuroprotection Mediated by Blockade of Microglial Activation                               (full – 2005)  http://www.jneurosci.org/cgi/content/full/25/8/1904

 

Avoidance of Abeta[(25-35)] / (H(2)O(2)) -induced apoptosis in lymphocytes by the cannabinoid agonists CP55,940 and JWH-015 via receptor-independent and PI3K- dependent mechanisms: role of NF-kappaB and p53.                                                          (abst – 2005)  http://www.ncbi.nlm.nih.gov/pubmed/17017986

 

Phosphorylated amyloid-beta: the toxic intermediate in alzheimer’s disease neurodegeneration.                                       (abst – 2005)         http://www.ncbi.nlm.nih.gov/pubmed/15709490

 

Cannabinoid control of motor function at the basal ganglia.       (abst – 2005)

http://www.ncbi.nlm.nih.gov/pubmed/16596785

 

Marijuana Ingredient May Stall Decline From Alzheimer’s        (news – 2005)

http://www.sciencedaily.com/releases/2005/02/050224111638.htm

 

Research shows preventive effects of cannabinoids on Alzheimer’s disease (news – 2005)                                http://www.news-medical.net/news/2005/02/22/7901.aspx

 

Marijuana Slows Alzheimer’s Decline             (news – 2005)

http://www.mapinc.org/drugnews/v05/n307/a10.html

 

Marijuana May Block Alzheimer’s            (news – 2005)

http://news.bbc.co.uk/2/hi/health/4286435.stm

 

Marijuana Ingredient May Help Alzheimer’s          (news – 2005)

http://www.webmd.com/alzheimers/news/20050223/marijuana-ingredient-may-help-alzheimers

 

Cannabinoids reduce the progression of Alzheimer’s disease in animals        (news – 2005)

http://www.cannabis-med.org/english/bulletin/ww_en_db_cannabis_artikel.php?id=187#1

 

Pass the Doobie, pops         (news – 2005)

http://www.thefreelibrary.com/Pass+the+doobie%2c+pops.-a0131273013

 

The Cannabinoid CB2 Receptor as a Target for Inflammation-Dependent Neurodegeneration                                         (full – 2006)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2435344/?tool=pmcentrez

 

A Molecular Link between the Active Component of Marijuana and Alzheimer’s Disease Pathology                      (full – 2006)        http://www.ukcia.org/research/AlzheimersDiseasePathology.pdf

 

Delta-9-tetrahydrocannabinol for nighttime agitation in severe dementia

(full – 2006)         http://science.iowamedicalmarijuana.org/pdfs/neuro/Walther%202006.pdf

 

Endocannabinoids and beta-amyloid-induced neurotoxicity in vivo: effect of pharmacological elevation of endocannabinoid levels.                                    (abst – 2006)  http://www.ncbi.nlm.nih.gov/pubmed/16732431

 

Cannabidiol inhibits inducible nitric oxide synthase protein expression and nitric oxide production in beta-amyloid stimulated PC12 neurons through p38 MAP kinase and NF- kappaB involvement.   (abst – 2006)                                         http://www.ncbi.nlm.nih.gov/pubmed/16490313

 

The marijuana component cannabidiol inhibits beta-amyloid-induced tau protein hyperphosphorylation through Wnt/beta-catenin pathway rescue in PC12 cells. (abst – 2006)                                   http://www.ncbi.nlm.nih.gov/pubmed/16389547

 

CB1 receptor selective activation inhibits beta-amyloid-induced iNOS protein expression in C6 cells and subsequently blunts tau protein hyperphosphorylation in co-cultured neurons. (abst – 2006)                     http://www.ncbi.nlm.nih.gov/pubmed/16837132

 

Marijuana Compound Efficient Against Alzheimer’s Disease (news – 2006)

http://news.softpedia.com/news/Marijuana-Compound-Efficient-against-Alzheimer-s-Disease-37410.shtml

 

THC inhibits primary marker of Alzheimer’s disease         (news – 2006)

http://www.cannabis-med.org/english/bulletin/ww_en_db_cannabis_artikel.php?id=225#3

 

Marijuana’s Active Ingredient Shown to Inhibit Primary Marker of Alzheimer’s Disease (news – 2006)                                 http://www.scripps.edu/newsandviews/e_20060828/news.html

 

Marijuana’s Active Ingredient May Slow Progression Of Alzheimer’s Disease (news – 2006)                               http://www.sciencedaily.com/releases/2006/10/061009031544.htm

 

Marijuana may help stave off Alzheimer’s       (news – 2006)

http://www.msnbc.msn.com/id/15145917/

 

Marijuana May Slow Alzheimer’s         (news – 2006)

http://www.webmd.com/alzheimers/news/20061006/marijuana-may-slow-alzheimers

 

Pot-Like Compound May Slow Alzheimer’s        (news – 2006)

http://www.webmd.com/alzheimers/news/20061019/pot-like-compound-may-slow-alzheimers

 

Latest Buzz: Marijuana May Slow Progression Of Alzheimer’s Disease       (news – 2006)

http://www.sciencedaily.com/releases/2006/10/061018151055.htm

 

Alzheimer’s disease; taking the edge off with cannabinoids?        (full – 2007)

http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pubmed&pubmedid=17828287

 

Cannabidiol in vivo blunts β-amyloid induced neuroinflammation by suppressing IL-1β and iNOS expression                         (full – 2007)  http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2189818&tool=pmcentrez

 

Opposing control of cannabinoid receptor stimulation on amyloid-beta-induced reactive gliosis: in vitro and in vivo evidence.                                        (full – 2007)  http://jpet.aspetjournals.org/content/322/3/1144.long

 

Anti-inflammatory property of the cannabinoid agonist WIN-55212-2 in a rodent model of chronic brain inflammation                                    (full – 2007)  http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1852513&tool=pmcentrez

 

The endocannabinoid system in targeting inflammatory neurodegenerative diseases (full – 2007)

http://medicalcannabis.com/images/pdf09/indications/neurodegenerative/centonze_et_al_2007_inflammato  ry_neuro.pdf

 

Cannabinoid CB2 receptors in human brain inflammation       (full – 2008)

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2219537/

 

Cannabinoid receptor stimulation is anti-inflammatory and improves memory in old rats (full – 2008)                           http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2586121/?tool=pmcentrez

 

Cannabinoids as Therapeutic Agents for Ablating Neuroinflammatory Disease (full – 2008)                           http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2750822/?tool=pmcentrez

 

Inflammation and aging: can endocannabinoids help?       (full – 2008)

http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2408719&tool=pmcentrez

 

Amyloid precursor protein 96-110 and beta-amyloid 1-42 elicit developmental anomalies in sea urchin embryos and larvae that are alleviated by neurotransmitter analogs for acetylcholine, serotonin and cannabinoids.                                                      (full – 2008)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2579926/?tool=pubmed

 

Role of CB2 receptors in neuroprotective effects of cannabinoids.      (abst – 2008)

http://www.ncbi.nlm.nih.gov/pubmed/18291574

 

The role of the endocannabinoid system in Alzheimer’s disease: facts and hypotheses. (abst – 2008)                                 http://www.ncbi.nlm.nih.gov/pubmed/18781980

 

Scientists are High on Idea that Cannabis Reduces Memory Impairment      (news – 2008)

http://www.physorg.com/news146320102.html

 

Israeli Research Shows Cannabidiol May Slow Alzheimer’s Disease       (news – 2008)

http://www.israelnationalnews.com/News/News.aspx/125564

 

Marijuana may be good for the aging brain        (news – 2008)

http://www.news-medical.net/news/2008/11/19/43212.aspx

 

Alzheimer’s sufferers may benefit from cannabis compound       (news – 2008)

http://www.news-medical.net/news/2008/03/11/36068.aspx

 

Marijuana reduces memory impairment        (news – 2008)

http://www.healthnewstrack.com/health-news-811.html

 

Cannabis ‘could stop dementia in its tracks’        (news – 2008)

http://www.dailymail.co.uk/health/article-1087544/Cannabis-stop-dementia-tracks.html

 

LSUHSC research reports new method to protect brain cells from diseases like Alzheimer’s  (news – 2008)                       http://www.eurekalert.org/pub_releases/2008-08/lsuh-lrr082008.php

 

Could Marijuana Substance Help Prevent Or Delay Memory Impairment In The Aging Brain?          (news – 2008)         http://www.sciencedaily.com/releases/2008/11/081119120141.htm

 

Attacking Alzheimer’s with Red Wine and Marijuana          (news – 2008)

http://www.alternet.org/story/110806/

 

Can cannabis offer hope for Alzheimer’s?           (news – 2008)

http://www.redorbit.com/news/health/1291704/can_cannabis_offer_hope_for_alzheimers/

 

Cannabis-derived medicines may help Alzheimer’s        (news – 2008)

http://www.news-medical.net/news/2008/03/10/36024.aspx

 

Pot joins the fight against Alzheimer’s, memory loss         (news – 2008)  http://www.scientificamerican.com/blog/60-second-science/post.cfm?id=pot-joins-the-fight-against- alzheim-2008-11-19

 

Emerging Role of the CB2 Cannabinoid Receptor in Immune Regulation and Therapeutic Prospects                              (full – 2009)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2768535/?tool=pmcentrez

 

Cannabidiol: a promising drug for neurodegenerative disorders?       (full – 2009)

http://onlinelibrary.wiley.com/doi/10.1111/j.1755-5949.2008.00065.x/full

 

The activation of cannabinoid CB2 receptors stimulates in situ and in vitro beta-amyloid removal by human macrophages.                                         (abst – 2009)  http://www.ncbi.nlm.nih.gov/pubmed/19505450?itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPa   nel.Pubmed_RVDocSum&ordinalpos=18

 

Endocannabinoids prevent lysosomal membrane destabilisation evoked by treatment with β-amyloid in cultured rat cortical neurons                             (abst – 2009)

http://forum.grasscity.com/medical-marijuana-usage-applications/1029121-alzheimers-  study.html#post14325992

 

Medical Marijuana and Alzheimer’s Disease        (news – 2009)

https://www.marijuanadoctors.com/content/ailments/view/76?ailment=alzheimer-s-disease

 

Enhancement of endocannabinoid signaling by fatty acid amide hydrolase inhibition: a neuroprotective therapeutic modality.                                  (full – 2010)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2848893/?tool=pubmed

 

Cannabinoid agonist WIN-55,212-2 partially restores neurogenesis in the aged rat brain (full – 2010)                             http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3011092/?tool=pubmed

 

Cannabinoids and Dementia: A Review of Clinical and Preclinical Data (link to PDF – 2010)                              http://www.mdpi.com/1424-8247/3/8/2689

 

The development of cannabinoid CBII receptor agonists for the treatment of central neuropathies.   (abst – 2010)  http://www.unboundmedicine.com/medline/ebm/record/20236042/abstract/The_development_of_cannabin  oid_CBII_receptor_agonists_for_the_treatment_of_central_neuropathies_

 

Endocannabinoids Prevent β-Amyloid-mediated Lysosomal Destabilization in Cultured Neurons    (abst – 2010)           http://www.jbc.org/content/285/49/38543.abstract

 

The endocannabinoid system in gp120-mediated insults and HIV-associated dementia. (abst – 2010)                            http://www.ncbi.nlm.nih.gov/pubmed/20353779

 

The Multiplicity of Action of Cannabinoids: Implications for Treating Neurodegeneration.    (abst – 2010)                              http://www.ncbi.nlm.nih.gov/pubmed/20875047

 

Marijuana could prevent Alzheimer’s       (news – 2010)

http://www.thelantern.com/mobile/2.1345/marijuana-could-prevent-alzheimer-s-1.72932

 

Newly discovered mechanism controls levels and efficacy of a marijuana-like substance in the brain (news – 2010)

http://www.eurekalert.org/pub_releases/2010-08/uow-ndm080610.php

 

Cannabidiol and other cannabinoids reduce microglial activation in vitro and in vivo: relevance to Alzheimers’ disease                           (full – 2011)  http://molpharm.aspetjournals.org/content/early/2011/02/24/mol.111.071290.long

 

Cannabidiol Reduces Aβ-Induced Neuroinflammation and Promotes Hippocampal Neurogenesis through PPARγ Involvement                               (full – 2011)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3230631/?tool=pubmed

 

Gadolinium-HU-308-incorporated micelles.         (full – 2011)

http://www.ncbi.nlm.nih.gov/books/NBK54067/pdf/CB2R-Gd-Micelles.pdf

 

US Patent Application 20110257256 – CANNABINOIDS FOR USE IN TREATING OR PREVENTING COGNITIVE IMPAIRMENT AND DEMENTIA                               (full – 2011)

http://www.patentstorm.us/applications/20110257256/fulltext.html

 

Is lipid signaling through cannabinoid 2 receptors part of a protective system? (full – 2011)                          http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3062638/

 

Anandamide and its congeners inhibit human plasma butyrylcholinesterase. Possible new roles for these endocannabinoids?                                 (abst – 2011)  http://www.ncbi.nlm.nih.gov/pubmed/21664223

 

Cannabidiol as an emergent therapeutic strategy for lessening the impact of inflammation on oxidative stress.                                      (abst – 2011)             http://www.ncbi.nlm.nih.gov/pubmed/21238581

 

An amyloid β(42)-dependent deficit in anandamide mobilization is associated with cognitive dysfunction in Alzheimer’s disease                                                    (abst – 2011) http://www.unboundmedicine.com/medline/ebm/record/21546126/abstract/An_amyloid_%CE%B2_42          d

ependent_deficit_in_anandamide_mobilization_is_associated_with_cognitive_dysfunction_in_Alzheimer%  27s_disease_

 

Molecular reorganization of endocannabinoid signalling in Alzheimer’s disease. (abst – 2011)

http://www.unboundmedicine.com/medline/ebm/record/21459826/abstract/Molecular_reorganization_of_e ndocannabinoid_signalling_in_Alzheimer%27s_disease_

 

Palmitoylethanolamide counteracts reactive astrogliosis induced by beta-amyloid peptide. (abst – 2011)                              http://www.ncbi.nlm.nih.gov/pubmed/21255263

 

The role of phytochemicals in the treatment and prevention of dementia.       (abst – 2011)  http://www.unboundmedicine.com/medline/ebm/record/21639405/abstract/The_role_of_phytochemicals_i   n_the_treatment_and_prevention_of_dementia_

 

Early onset of aging-like changes is restricted to cognitive abilities and skin structure in Cnr1(-/-) mice.                              (abst – 2011)           http://www.ncbi.nlm.nih.gov/pubmed/20724033

 

 

Intact cannabinoid CB1 receptors in the Alzheimer’s disease cortex.      (abst – 2011)

http://www.ncbi.nlm.nih.gov/pubmed/21034788

 

The effects of hempseed meal intake and linoleic acid on Drosophila models of neurodegenerative diseases and hypercholesterolemia.                                        (abst – 2011)  http://www.ncbi.nlm.nih.gov/pubmed/21331775

 

Endocannabinoid 2-arachidonoylglycerol protects neurons against β-amyloid insults. (abst – 2011)  http://www.unboundmedicine.com/medline/ebm/record/21256197/abstract/Endocannabinoid_2_arachidono  ylglycerol_protects_neurons_against_%CE%B2_amyloid_insults_

 

New metabolic pathway for controlling brain inflammation          (news – 2011)  http://www.news-medical.net/news/20111021/New-metabolic-pathway-for-controlling-brain-  inflammation.aspx

 

Can the benefits of cannabinoid receptor stimulation on neuroinflammation, neurogenesis and memory during normal aging be useful in AD prevention?                                         (full – 2012)  http://www.jneuroinflammation.com/content/9/1/10

 

Prolonged oral Cannabinoid Administration prevents Neuroinflammation, lowers beta- amyloid Levels and improves Cognitive Performance in Tg APP 2576 Mice.

(full – 2012)         http://www.jneuroinflammation.com/content/pdf/1742-2094-9-8.pdf

 

A Dysregulated Endocannabinoid-Eicosanoid Network Supports Pathogenesis in a Mouse Model of Alzheimer’s Disease                                     (full – 2012)

http://download.cell.com/cell-reports/mmcs/journals/2211-1247/PIIS2211124712001258.mmc2.pdf

 

Monoacylglycerol lipase is a new therapeutic target for Alzheimer’s disease (full – 2012)                             http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3513645/

 

Palmitoylethanolamide exerts neuroprotective effects in mixed neuroglial cultures and organotypic hippocampal slices via peroxisome proliferator-activated receptor-α

(full – 2012)       http://www.jneuroinflammation.com/content/9/1/49

 

The fatty acid amide hydrolase inhibitor URB597 exerts anti-inflammatory effects in hippocampus of aged rats and restores an age-related deficit in long-term potentiation (full – 2012)                             http://www.jneuroinflammation.com/content/9/1/79

 

Can the benefits of cannabinoid receptor stimulation on neuroinflammation, neurogenesis and memory during normal aging be useful in AD prevention?                                         (full – 2012)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3284401/?tool=pubmed

 

Methylhonokiol attenuates neuroinflammation: a role for cannabinoid receptors? (full – 2012)                             http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3419612/

 

Palmitoylethanolamide exerts neuroprotective effects in mixed neuroglial cultures and organotypic hippocampal slices via peroxisome proliferator-activated receptor-α.

(full – 2012)          http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3315437/?tool=pubmed

 

The endocannabinoid, anandamide, augments Notch-1 signaling in cultured cortical neurons exposed to amyloid-beta and in the cortex of aged rats.                                          (full – 2012)  http://www.jbc.org/content/early/2012/08/13/jbc.M112.350678.long

 

Review article: The endocannabinoid system in normal and pathological brain ageing (abst – 2012)                                http://www.ncbi.nlm.nih.gov/pubmed/23108550

 

Activation of the CB(2) receptor system reverses amyloid-induced memory deficiency. (abst – 2012)                                http://www.ncbi.nlm.nih.gov/pubmed/22795792

 

Protective effect of cannabinoid CB1 receptor activation against altered intrinsic repetitive firing properties induced by Aβ neurotoxicity.                                 (abst – 2012)  http://www.ncbi.nlm.nih.gov/pubmed/22172925

 

Contrasting protective effects of cannabinoids against oxidative stress and amyloid-β evoked neurotoxicity in vitro.                                       (abst – 2012)    http://www.ncbi.nlm.nih.gov/pubmed/22233683

 

[(125)I]SD-7015 reveals fine modalities of CB(1) cannabinoid receptor density in the prefrontal cortex during progression of Alzheimer’s disease.                                    (abst – 2012)  http://www.ncbi.nlm.nih.gov/pubmed/22222721

 

CB1 Agonist ACEA Protects Neurons and Reduces the Cognitive Impairment of AβPP/PS1 Mice.                                  (abst – 2012)         http://www.ncbi.nlm.nih.gov/pubmed/22451318

 

CB1 cannabinoid receptor activation rescues amyloid β-induced alterations in behaviour and intrinsic electrophysiological properties of rat hippocampal CA1 pyramidal neurones. (abst – 2012)                              http://www.ncbi.nlm.nih.gov/pubmed/22508047

 

The therapeutic potential of the endocannabinoid system for Alzheimer’s disease. (abst – 2012)                              http://www.ncbi.nlm.nih.gov/pubmed/22448595

 

WIN55212-2 attenuates amyloid-beta-induced neuroinflammation in rats through activation of cannabinoid receptors and PPAR-γ pathway.                            (abst – 2012)  http://www.ncbi.nlm.nih.gov/pubmed/22634229

 

CB(2) receptor and amyloid pathology in frontal cortex of Alzheimer’s disease patients. (abst – 2012)                              http://www.ncbi.nlm.nih.gov/pubmed/22763024

 

In vivo type 1 cannabinoid receptor availability in Alzheimer’s disease        (abst – 2012)

http://jnumedmtg.snmjournals.org/cgi/content/meeting_abstract/53/1_MeetingAbstracts/1961?maxtoshow=

&hits=25&RESULTFORMAT=&fulltext=cannabinoid&searchid=1&FIRSTINDEX=130&sortspec=date&  resourcetype=HWCIT

 

Essential fatty acids and lipid mediators. Endocannabinoids         (abst – 2012)

http://www.ncbi.nlm.nih.gov/pubmed/22730630

 

β−Amyloid exacerbates inflammation in astrocytes lacking fatty acid amide hydrolase through a mechanism involving PPAR-α, PPAR-γ and TRPV1, but not CB1 or CB2 receptors        (abst – 2012)

http://onlinelibrary.wiley.com/doi/10.1111/j.1476-5381.2012.01889.x/abstract

 

How Weed Can Protect Us From Cancer and Alzheimer’s       (book excerpt – 2012)

http://www.alternet.org/story/156269/how_weed_can_protect_us_from_cancer_and_alzheimer%27s

 

Marijuana Compound Found Superior To Drugs For Alzheimer’s (news – 2012)  http://www.laleva.org/eng/2012/09/marijuana_compound_found_superior_to_drugs_for_alzheimers –   print.html

 

How Cannabinoids May Slow Brain Aging         (news – 2012)

http://healthland.time.com/2012/10/29/how-cannabinoids-may-slow-brain-aging/

 

Cannabinoid Receptor Stimulator Reverses Symptoms of Alzheimer’s Disease in Animal Model                 (news – 2012)        http://www.biotechdaily.com/?option=com_article&Itemid=294742494

 

Researchers investigating potential drug for treatement of Alzheimer’s disease (news – 2012)

http://medicalxpress.com/news/2012-08-potential-drug-treatement-alzheimer-disease.html

 

Research identifies new therapeutic target for Alzheimer’s disease      (news – 2012)

http://medicalxpress.com/news/2012-11-therapeutic-alzheimer-disease.html

 

Activation of the CB(2) receptor system reverses amyloid-induced memory deficiency. (abst – 2013)                              http://www.ncbi.nlm.nih.gov/pubmed/22795792

 

CB(2) receptor and amyloid pathology in frontal cortex of Alzheimer’s disease patients. (abst – 2013)                              http://www.ncbi.nlm.nih.gov/pubmed/22763024

 

Multitarget Cannabinoids as Novel Strategy for Alzheimer Disease.        (abst – 2013)

http://www.ncbi.nlm.nih.gov/pubmed/23369066

 

 

Share a link for